Literature DB >> 19709731

HIV infection and tuberculosis in South Africa: an urgent need to escalate the public health response.

Salim S Abdool Karim1, Gavin J Churchyard, Quarraisha Abdool Karim, Stephen D Lawn.   

Abstract

One of the greatest challenges facing post-apartheid South Africa is the control of the concomitant HIV and tuberculosis epidemics. HIV continues to spread relentlessly, and tuberculosis has been declared a national emergency. In 2007, South Africa, with 0.7% of the world's population, had 17% of the global burden of HIV infection, and one of the world's worst tuberculosis epidemics, compounded by rising drug resistance and HIV co-infection. Until recently, the South African Government's response to these diseases has been marked by denial, lack of political will, and poor implementation of policies and programmes. Nonetheless, there have been notable achievements in disease management, including substantial improvements in access to condoms, expansion of tuberculosis control efforts, and scale-up of free antiretroviral therapy (ART). Care for acutely ill AIDS patients and long-term provision of ART are two issues that dominate medical practice and the health-care system. Decisive action is needed to implement evidence-based priorities for the control of the HIV and tuberculosis epidemics. By use of the framework of the Strategic Plans for South Africa for tuberculosis and HIV/AIDS, we provide prioritised four-step approaches for tuberculosis control, HIV prevention, and HIV treatment. Strong leadership, political will, social mobilisation, adequate human and financial resources, and sustainable development of health-care services are needed for successful implementation of these approaches.

Entities:  

Mesh:

Year:  2009        PMID: 19709731      PMCID: PMC2803032          DOI: 10.1016/S0140-6736(09)60916-8

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  35 in total

Review 1.  Demography and economics of HIV/AIDS.

Authors:  A Whiteside
Journal:  Br Med Bull       Date:  2001       Impact factor: 4.291

2.  Characterization of full-length HIV type 1 subtype C sequences from South Africa.

Authors:  J van Harmelen; C Williamson; B Kim; L Morris; J Carr; S S Karim; F McCutchan
Journal:  AIDS Res Hum Retroviruses       Date:  2001-11-01       Impact factor: 2.205

3.  Antiretroviral therapy: challenges and options in South Africa.

Authors:  Salim S Abdool Karim; Quarraisha Abdool Karim; Cheryl Baxter
Journal:  Lancet       Date:  2003-11-01       Impact factor: 79.321

4.  Workplace discrimination. Helping the spread of HIV.

Authors:  Z Achmat; E Cameron
Journal:  S Afr Labour Bull       Date:  1995-11

5.  Tuberculosis and the development of industrial health policies on the Witwatersrand, 1902-1932.

Authors:  R M Packard
Journal:  J South Afr Stud       Date:  1987

Review 6.  Treatment of latent tuberculosis infection in HIV infected persons.

Authors:  S Woldehanna; J Volmink
Journal:  Cochrane Database Syst Rev       Date:  2004

7.  Tuberculosis epidemics driven by HIV: is prevention better than cure?

Authors:  Christine S M Currie; Brian G Williams; Russell C H Cheng; Christopher Dye
Journal:  AIDS       Date:  2003-11-21       Impact factor: 4.177

8.  The impact of migration on HIV-1 transmission in South Africa: a study of migrant and nonmigrant men and their partners.

Authors:  Mark N Lurie; Brian G Williams; Khangelani Zuma; David Mkaya-Mwamburi; Geoff Garnett; Adriaan W Sturm; Michael D Sweat; Joel Gittelsohn; Salim S Abdool Karim
Journal:  Sex Transm Dis       Date:  2003-02       Impact factor: 2.830

9.  Who infects whom? HIV-1 concordance and discordance among migrant and non-migrant couples in South Africa.

Authors:  Mark N Lurie; Brian G Williams; Khangelani Zuma; David Mkaya-Mwamburi; Geoff P Garnett; Michael D Sweat; Joel Gittelsohn; Salim S Abdool Karim
Journal:  AIDS       Date:  2003-10-17       Impact factor: 4.177

Review 10.  Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients: a collaborative analysis of 18 HIV cohort studies.

Authors:  Jonathan A C Sterne; Margaret May; Dominique Costagliola; Frank de Wolf; Andrew N Phillips; Ross Harris; Michele Jönsson Funk; Ronald B Geskus; John Gill; François Dabis; Jose M Miró; Amy C Justice; Bruno Ledergerber; Gerd Fätkenheuer; Robert S Hogg; Antonella D'Arminio Monforte; Michael Saag; Colette Smith; Schlomo Staszewski; Matthias Egger; Stephen R Cole
Journal:  Lancet       Date:  2009-04-08       Impact factor: 79.321

View more
  196 in total

Review 1.  Nanoparticle delivery of anti-tuberculosis chemotherapy as a potential mediator against drug-resistant tuberculosis.

Authors:  Jonathan Paul Smith
Journal:  Yale J Biol Med       Date:  2011-12

2.  Antiretroviral therapy refusal among newly diagnosed HIV-infected adults.

Authors:  Ingrid T Katz; Thandekile Essien; Edmore T Marinda; Glenda E Gray; David R Bangsberg; Neil A Martinson; Guy De Bruyn
Journal:  AIDS       Date:  2011-11-13       Impact factor: 4.177

3.  Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women.

Authors:  Quarraisha Abdool Karim; Salim S Abdool Karim; Janet A Frohlich; Anneke C Grobler; Cheryl Baxter; Leila E Mansoor; Ayesha B M Kharsany; Sengeziwe Sibeko; Koleka P Mlisana; Zaheen Omar; Tanuja N Gengiah; Silvia Maarschalk; Natasha Arulappan; Mukelisiwe Mlotshwa; Lynn Morris; Douglas Taylor
Journal:  Science       Date:  2010-07-19       Impact factor: 47.728

4.  Mortality associated with tuberculosis/HIV co-infection among patients on TB treatment in the Limpopo province, South Africa.

Authors:  Tiyani E Mabunda; Nalezani J Ramalivhana; Yoswa M Dambisya
Journal:  Afr Health Sci       Date:  2014-12       Impact factor: 0.927

5.  Risk Factors for HIV Acquisition in High Risk Women in a Generalised Epidemic Setting.

Authors:  Nivashnee Naicker; Ayesha B M Kharsany; Lise Werner; Francois van Loggerenberg; Koleka Mlisana; Nigel Garrett; Salim S Abdool Karim
Journal:  AIDS Behav       Date:  2015-07

6.  Social constraints to TB/HIV healthcare: accounts from coinfected patients in South Africa.

Authors:  Amrita Daftary; Nesri Padayatchi
Journal:  AIDS Care       Date:  2012-04-24

7.  Antiretroviral therapy and the control of HIV-associated tuberculosis. Will ART do it?

Authors:  S D Lawn; A D Harries; B G Williams; R E Chaisson; E Losina; K M De Cock; R Wood
Journal:  Int J Tuberc Lung Dis       Date:  2011-05       Impact factor: 2.373

8.  Chronic lung disease in adult recurrent tuberculosis survivors in Zimbabwe: a cohort study.

Authors:  A T Chin; J Rylance; S Makumbirofa; S Meffert; T Vu; J Clayton; P Mason; P Woodruff; J Metcalfe
Journal:  Int J Tuberc Lung Dis       Date:  2019-02-01       Impact factor: 2.373

9.  Stabilizing HIV prevalence masks high HIV incidence rates amongst rural and urban women in KwaZulu-Natal, South Africa.

Authors:  Quarraisha Abdool Karim; Ayesha B M Kharsany; Janet A Frohlich; Lise Werner; May Mashego; Mukelisiwe Mlotshwa; Bernadette T Madlala; Fanelesibonge Ntombela; Salim S Abdool Karim
Journal:  Int J Epidemiol       Date:  2010-11-03       Impact factor: 7.196

10.  The hidden harm of home-based care: pulmonary tuberculosis symptoms among children providing home medical care to HIV/AIDS-affected adults in South Africa.

Authors:  Lucie Cluver; Mark Orkin; Mosa Moshabela; Caroline Kuo; Mark Boyes
Journal:  AIDS Care       Date:  2013-03-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.